ClinicalTrials.gg
Sign In

Drug

Thrombopoietin Receptor Agonist clinical trials

studies test it
5
open now
3
in phase 3
0
first study started
2021

Keep track of what changes. Save the Thrombopoietin Receptor Agonist studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

thrombopoietin receptor agonist (TPO-RA)
2
thrombopoietin receptor agonist
1

Studies by the year they started

5 studies that test it; most in 2026 (2)

Studies that test Thrombopoietin Receptor Agonist, by start year
YearStudies
20211
20221
20251
20262

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
3
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Purpura, Thrombocytopenic, Idiopathic
3
Anemia, Aplastic
1
Thrombocytopenia
1

Who runs them

Industry 2 · Other 3

Chongqing Peg-Bio Biopharm Co., Ltd. (1) · Peking Union Medical College Hospital (1) · Novartis Pharmaceuticals (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · The First Affiliated Hospital of Zhengzhou University (1)

Often tested with

Tested in the same studies.

Cyclosporine (1) · Romiplostim (1) · Ianalumab (1) · Recombinant human thrombopoietin (1)

Studies

Open first, then newest update. How each study uses Thrombopoietin Receptor Agonist is read from its arms, and is right about nine times in ten.

Testing it · 5

Given in every arm · 5 — Thrombopoietin Receptor Agonist is usual care beside what is tested